13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001104659-25-049337
Total Value
$644.6M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 815,176 | $95.1M | 14.75% |
| 2 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $76.5M | 11.87% |
| 3 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $64.8M | 10.06% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 3,202,798 | $63.0M | 9.78% |
| 5 | NUVALENT INC | NUVL | 727,563 | $51.6M | 8.00% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 2,700,691 | $49.0M | 7.60% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,445,813 | $46.4M | 7.21% |
| 8 | SCHOLAR ROCK HLDG CORP | SRRK | 1,374,031 | $44.2M | 6.85% |
| 9 | COGENT BIOSCIENCES INC | COGT | 6,225,641 | $37.3M | 5.79% |
| 10 | ORUKA THERAPEUTICS INC | ORKA | 3,371,922 | $34.6M | 5.37% |
| 11 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 1,102,248 | $24.5M | 3.80% |
| 12 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $19.0M | 2.94% |
| 13 | ZENAS BIOPHARMA INC | ZBIO | 1,892,806 | $15.0M | 2.32% |
| 14 | INHIBIKASE THERAPEUTICS INC | IKT | 6,125,000 | $13.4M | 2.08% |
| 15 | BICARA THERAPEUTICS INC | BCAX | 784,170 | $10.2M | 1.59% |